BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 12599220)

  • 1. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?
    Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E
    Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
    Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
    Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
    Yeh S; Tan LR; O'Connell TX
    Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma.
    Jackson JS; Olivotto IA; Wai M D E; Grau C; Mates D; Ragaz J
    Cancer; 2000 Apr; 88(8):1852-62. PubMed ID: 10760762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
    Shahar KH; Hunt KK; Thames HD; Ross MI; Perkins GH; Kuerer HM; Strom EA; McNeese MD; Meric F; Schechter NR; Sahin AA; Middleton LP; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1074-9. PubMed ID: 15234041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
    Swenson KK; Mahipal A; Nissen MJ; Tuttle TM; Heaton K; Lally RM; Spomer A; Lee MW
    Cancer; 2005 Nov; 104(9):1834-9. PubMed ID: 16161037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative therapy for elderly patients with breast cancer.
    von Rueden DG; Sessions SC
    Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection.
    Fujimoto N; Amemiya A; Kondo M; Takeda A; Shigematsu N
    Cancer; 2004 Nov; 101(10):2155-63. PubMed ID: 15476272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y
    Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.